UArizona Health Sciences Joint Study Finds Dual Inhibitor Strategy May Be Key To Sustainable COVID-19 Treatment

UArizona Pharmacology and Toxicology researcher and BIO5 member Dr. Jun Wang, has identified a way to develop new drugs to treat COVID-19 by targeting two inhibiting compounds of the virus's replication process. Understanding how these compounds interact and act as inhibitors will allow researchers to design better drug candidates for COVID-19 and other seasonal human coronaviruses.